AADI - Aadi Bioscience Inc. (AADI) CEO Neil Desai on Q1 2022 Results - Earnings Call Transcript
Aadi Bioscience, Inc. (AADI) Q1 2022 Earnings Conference Call May 12, 2022, 08:30 ET Company Participants Andrew Quan - VP, Business Development & Corporate Strategy Neil Desai - Founder, President, CEO, Secretary & Director Brendan Delaney - COO Loretta Itri - Chief Medical Officer Scott Giacobello - CFO & Treasurer Conference Call Participants Boris Peaker - Cowen and Company Ahu Demir - Ladenburg Thalmann & Co. Joseph Catanzaro - Piper Sandler & Co. Jiale Song - Jefferies Presentation Operator Greetings, and welcome to the Aadi Bioscience, Inc. First Quarter 2021 Earnings Conference Call. [Operator Instructions]. It is now my pleasure to introduce your host, Andrew Quan, VP of Business Development and Corporate Strategy. Thank you. You may begin. Andrew Quan I would like to welcome everyone to the first Aadi Bioscience Quarterly Results Call for Q1 2022. With us on the call today from Aadi Bioscience are Neil Desai, Founder,
For further details see:
Aadi Bioscience, Inc. (AADI) CEO Neil Desai on Q1 2022 Results - Earnings Call Transcript